262 related articles for article (PubMed ID: 21460253)
1. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia.
Moussay E; Wang K; Cho JH; van Moer K; Pierson S; Paggetti J; Nazarov PV; Palissot V; Hood LE; Berchem G; Galas DJ
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6573-8. PubMed ID: 21460253
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
[TBL] [Abstract][Full Text] [Related]
3. CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
Sivina M; Hartmann E; Kipps TJ; Rassenti L; Krupnik D; Lerner S; LaPushin R; Xiao L; Huang X; Werner L; Neuberg D; Kantarjian H; O'Brien S; Wierda WG; Keating MJ; Rosenwald A; Burger JA
Blood; 2011 Feb; 117(5):1662-9. PubMed ID: 21115978
[TBL] [Abstract][Full Text] [Related]
4. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
[TBL] [Abstract][Full Text] [Related]
5. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
[TBL] [Abstract][Full Text] [Related]
6. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
[TBL] [Abstract][Full Text] [Related]
7. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.
Fathullahzadeh S; Mirzaei H; Honardoost MA; Sahebkar A; Salehi M
Cancer Gene Ther; 2016 Oct; 23(10):327-332. PubMed ID: 27659777
[TBL] [Abstract][Full Text] [Related]
9. Karyotype-specific microRNA signature in chronic lymphocytic leukemia.
Visone R; Rassenti LZ; Veronese A; Taccioli C; Costinean S; Aguda BD; Volinia S; Ferracin M; Palatini J; Balatti V; Alder H; Negrini M; Kipps TJ; Croce CM
Blood; 2009 Oct; 114(18):3872-9. PubMed ID: 19717645
[TBL] [Abstract][Full Text] [Related]
10. Detection of ZAP-70 in patients with chronic lymphocytic leukemia.
Marjanovic G; Stanojevic I; Jankovic-Velickovic Lj; Hubl W; Marjanovic V
J BUON; 2008; 13(4):543-6. PubMed ID: 19145677
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
[TBL] [Abstract][Full Text] [Related]
12. Blood collection methods affect cellular protein integrity: implications for clinical trial biomarkers and ZAP-70 in CLL.
Chen LS; Keating MJ; Gandhi V
Blood; 2014 Aug; 124(7):1192-5. PubMed ID: 25124785
[No Abstract] [Full Text] [Related]
13. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Giannarelli D; Sperduti I; Molica M; Gentile M; Morabito F; Neri A; Ferrarini M
Int J Hematol; 2008 Nov; 88(4):374-380. PubMed ID: 18818986
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia.
Aguilar-Hernandez MM; Rincon Camacho JC; Galicia Garcia G
Curr Oncol Rep; 2021 Apr; 23(6):66. PubMed ID: 33855607
[TBL] [Abstract][Full Text] [Related]
16. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
Rivkina A; Vitols G; Murovska M; Lejniece S
Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
[TBL] [Abstract][Full Text] [Related]
17. Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.
Kim SZ; Chow KU; Kukoc-Zivojnov N; Boehrer S; Brieger A; Steimle-Grauer SA; Harder L; Hoelzer D; Mitrou PS; Weidmann E
Leuk Lymphoma; 2004 Oct; 45(10):2037-45. PubMed ID: 15370248
[TBL] [Abstract][Full Text] [Related]
18. Role of microRNAs in chronic lymphocytic leukemia (Review).
Zhou XX; Wang X
Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
[TBL] [Abstract][Full Text] [Related]
19. ZAP-70 protein expression in B-cell chronic lymphoid leukemia: a single center experience from Pakistan.
Zeeshan R; Irfan SM; Sultan S; Bhimani S
Asian Pac J Cancer Prev; 2015; 16(4):1587-90. PubMed ID: 25743836
[TBL] [Abstract][Full Text] [Related]
20. Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.
Stamatopoulos B; Van Damme M; Crompot E; Dessars B; Housni HE; Mineur P; Meuleman N; Bron D; Lagneaux L
Mol Med; 2015 Jan; 21(1):123-33. PubMed ID: 25584781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
